Association of PD-L1 mRNA levels in plasma-derived exosomes with response to nivolumab and pembrolizumab in melanoma and NSCLC. This is an ASCO Meeting Abstract from the 2018 ASCO-SITC Clinical Immuno ...

RemeGen Co., Ltd.(688331.SH / 09995.HK) announced that Telitacicept has officially been approved for marketing in China by the National Medical Products Administration (NMPA) for the treatment of ...

Adding Blenrep to standard therapy prolonged progression-free survival in patients with relapsed or refractory multiple ...

COVID-19 vaccine protection fades within months due to a lack of long-lived plasma cells. Booster shots restore some immunity ...

Explore plasma proteomics innovations tackling the dynamic range challenge, revealing biomarkers and advancing personalized ...

During a live event, Samuel M. Rubinstein, MD, discussed the efficacy and safety outcomes from the KarMMa-3 trial.

With its existing entitlement, plus the newly acquired economics from BioInvent, XOMA Royalty will be entitled to milestones of up to USD $16.25 million from Takeda and mid-single digit royalties on ...

Agency drug reviewers had questioned patient risk criteria and the efficacy endpoint used in a key trial supporting J&J's ...

Ronnie Haston died suddenly of blood cancer after being treated for constipation. Now, his stepdaughter is running a marathon ...

But it was during Christmas dinner that 66-year-old Jim Delaney's adult children, Emer, 27, and Kealan, 31, noticed an ...

Selagine, Inc., a spin-out company from the University of Illinois Chicago (UIC), announced today that the U.S. Food and Drug ...

The FDA has approved Johnson & Johnson's anti-FcRn antibody, nipocalimab, for the treatment of generalized myasthenia gravis. The drug will be sold under the brand name IMAAVY. This approval ...